Approved for use in the United States since 2017, it has recently seen a surge in popularity attributed to reports of off-label use for weight- loss promotion
In three separate SUSTAIN trials, semaglutide 1 mg conferred a greater weight loss among adults with type 2 diabetes than exenatide 2 mg (Bydureon, AstraZeneca), dulaglutide 1.5 mg (Trulicity, Eli Lilly) and liraglutide 1.8 mg (Saxenda, Novo Nordisk)
We review the medical history, baseline labs, weight-related conditions, medication risks, side effects, insurance barriers, muscle preservation, and the long-term maintenance plan
Poor hygiene and not keeping the skin clean and dry especially, in the skin folds can make you more proen to catching fungal infections
All information regarding this compound is strictly limited to laboratory-based research